ArticleOphthalmology and therapy2026
Spectrally Resolved (Colour-Coded) Fundus Autofluorescence Using the EIDON System in Vitreoretinal Lymphoma.
Article in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study evaluates colour-coded fundus autofluorescence (FAF) in vitreoretinal lymphoma (VRL), which still represents a diagnostic challenge because of the variety of ocular manifestations and difficulties in obtaining a definite diagnosis.
methodsRetrospective cross-sectional analysis of consecutive patients with VRL studied with colour-coded FAF. For comparative analysis, the patients also underwent conventional blue and green fundus FAF. Detection and appearance of typical VRL lesions in macular and extramacular locations on colour-coded FAF were studied and compared with other imaging techniques, including optical coherence tomography.
resultsWe evaluated 20 eyes from 10 patients affected by VRL. The agreement among readers on the presence of VRL lesions using colour-coded FAF was excellent. Lesion-specific comparative analysis showed that retinitis-like lesions were identified in 2/2 eyes using colour-coded FAF versus 0/2 eyes using blue FAF and green FAF, while lymphomatous retinal pigment epithelium (RPE) detachments were detected in 4/4 eyes using colour-coded FAF versus 1/4 eyes using blue FAF and green FAF. The classic granular appearance was similarly detected in 13/13 eyes across all FAF modalities. Comparative analysis revealed that colour-coded FAF appeared to better delineate retinitis-like lesions and lymphomatous RPE detachments than other types of FAF. Conversely, green FAF was more informative within the macula, while colour-coded FAF was also able to detect minor fluorophores and showed RPE atrophic areas, sub-RPE deposits, and perivascular infiltrates.
conclusionColour-coded FAF can recognize the classic features of VRL. As a complementary imaging modality, colour-coded FAF may facilitate the recognition of retinitis-like lesions, lymphomatous retinal pigment epithelium detachments, and minor fluorophores compared with other FAF types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.